Drugs / CD34+ Hematopoietic Progenitor Cells
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01660607 Background | Feb 2012 → Dec 2023 | acute lymphoblastic leukemia, acute myeloid leukemia, chronic myeloid leukemia, myelodysplastic syndrome | Stanford University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD34+ Hematopoietic Progenitor Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01660607 ↗ |
| Known as | HSPC | “CD34+ Hematopoietic Progenitor Cells (HSPC)” NCT01660607 ↗ |
| Modality | Cell therapy | “Biological: CD34+ Hematopoietic Progenitor Cells (HSPC)” NCT01660607 ↗ |